Literature DB >> 25545484

TUMORS OF THE NONPIGMENTED EPITHELIUM OF THE CILIARY BODY: The Lorenz E. Zimmerman Tribute Lecture.

Jerry A Shields1, Ralph C Eagle, Kyle Ferguson, Carol L Shields.   

Abstract

BACKGROUND: In 1970, Dr. Lorenz Zimmerman delivered the Norman McAlister Gregg Lecture entitled "The remarkable polymorphism of tumors of the ciliary epithelium." Therein, he proposed a classification of these tumors that included congenital lesions (mainly medulloepithelioma) and acquired lesions (mainly adenoma and adenocarcinoma). The classification was based on histopathologic observations without detailed clinical information.
METHODS: Review of the published literature and personal experience with tumors of the nonpigmented ciliary body epithelium.
RESULTS: Since 1970, further observations through clinical examination and advanced testing with ultrasound biomicroscopy, anterior segment optical coherence tomography, and magnetic resonance imaging have expanded our knowledge regarding tumors of the nonpigmented ciliary body epithelium. Regarding medulloepithelioma, we have learned of the common associated features of neovascular glaucoma, retrolenticular neoplastic or vascular cyclitic membrane, intralesional cysts, response to radiotherapy, and association with Dicer-1 mutation. Regarding adenoma/adenocarcinoma, improved management with surgical resection (sparing globe) can be achieved. Fuchs adenoma, also termed coronal adenoma, is commonly found histopathologically, despite its rare clinical visualization, and should be added to the Zimmerman classification.
CONCLUSION: Since Zimmerman's report on histopathologic features of tumors of the nonpigmented ciliary body epithelium, there have been numerous publications and further observations on the clinical features and management of these intriguing neoplasms.

Entities:  

Mesh:

Year:  2015        PMID: 25545484     DOI: 10.1097/IAE.0000000000000445

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Adenocarcinoma of the nonpigmented ciliary epithelium manifested as an anterior chamber mass.

Authors:  Hai-Xia Bai; Wen-Bin Wei; Bin Li; Xiao-Lin Xu; Wen-Li Yang; Fei Gao; Zhi-Bao Zhang
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

2.  DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study.

Authors:  Laryssa A Huryn; Amy Turriff; Laura A Harney; Ann Garrity Carr; Patricia Chevez-Barrios; Dan S Gombos; Radha Ram; Robert B Hufnagel; D Ashley Hill; Wadih M Zein; Kris Ann P Schultz; Rachel Bishop; Douglas R Stewart
Journal:  Ophthalmology       Date:  2018-10-17       Impact factor: 12.079

3.  Repeatability and Reliability of Quantified Ultrasound Biomicroscopy Image Analysis of the Ciliary Body at the Pars Plicata.

Authors:  Joy Li; Jennifer Drechsler; Anna Lin; Matthew Widlus; Azam Qureshi; Gianna Stoleru; Osamah Saeedi; M Roni Levin; Mona Kaleem; Mohamad Jaafar; William P Madigan; Janet Leath Alexander
Journal:  Ultrasound Med Biol       Date:  2021-04-13       Impact factor: 3.694

4.  Choroidal melanoma with synchronous Fuchs' adenoma and novel ATRX mutation.

Authors:  Elli Harford; Jane M Palmer; William J Glasson; Sunil K Warrier; Kevin J Whitehead; Kelly M Brooks; Peter A Johansson; Nicholas K Hayward; Lindsay A McGrath
Journal:  Int J Retina Vitreous       Date:  2022-04-01

Review 5.  DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.

Authors:  Iván A González; Douglas R Stewart; Kris Ann P Schultz; Amanda P Field; D Ashley Hill; Louis P Dehner
Journal:  Mod Pathol       Date:  2021-10-01       Impact factor: 7.842

6.  Ciliary body medulloepithelioma treated with intra-operative brachytherapy after fine needle aspiration biopsy.

Authors:  Amparo Ortiz-Seller; Rafael Martínez-Costa; José Pérez Calatayud; Inmaculada Almor Palacios; Ana Rodrigo Hernández; Honorio Barranco González
Journal:  J Contemp Brachytherapy       Date:  2022-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.